<SEC-DOCUMENT>0001193125-25-052211.txt : 20250312
<SEC-HEADER>0001193125-25-052211.hdr.sgml : 20250312
<ACCEPTANCE-DATETIME>20250311214833
ACCESSION NUMBER:		0001193125-25-052211
CONFORMED SUBMISSION TYPE:	6-K
PUBLIC DOCUMENT COUNT:		3
CONFORMED PERIOD OF REPORT:	20250311
FILED AS OF DATE:		20250312
DATE AS OF CHANGE:		20250311

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Nutrien Ltd.
		CENTRAL INDEX KEY:			0001725964
		STANDARD INDUSTRIAL CLASSIFICATION:	AGRICULTURE CHEMICALS [2870]
		ORGANIZATION NAME:           	08 Industrial Applications and Services
		IRS NUMBER:				981400416
		STATE OF INCORPORATION:			Z4
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		6-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-38336
		FILM NUMBER:		25729778

	BUSINESS ADDRESS:	
		STREET 1:		211 19TH STREET EAST
		STREET 2:		SUITE 1700
		CITY:			SASKATOON
		STATE:			A9
		ZIP:			S7K 5R6
		BUSINESS PHONE:		(306) 933-8500

	MAIL ADDRESS:	
		STREET 1:		211 19TH STREET EAST
		STREET 2:		SUITE 1700
		CITY:			SASKATOON
		STATE:			A9
		ZIP:			S7K 5R6
</SEC-HEADER>
<DOCUMENT>
<TYPE>6-K
<SEQUENCE>1
<FILENAME>d937713d6k.htm
<DESCRIPTION>6-K
<TEXT>
<HTML><HEAD>
<TITLE>6-K</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE" STYLE="line-height:Normal">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&nbsp;</P>
<P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P> <P STYLE="margin-top:30pt; margin-bottom:0pt; font-size:15pt; font-family:Times New Roman" ALIGN="center"><B>UNITED STATES </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:15pt; font-family:Times New Roman" ALIGN="center"><B>SECURITIES AND EXCHANGE COMMISSION </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Washington, D.C. 20549 </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:20pt; font-family:Times New Roman" ALIGN="center"><B>Form <FONT
STYLE="white-space:nowrap">6-K</FONT> </B></P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Report of
Foreign Private Issuer </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Pursuant to Rule <FONT STYLE="white-space:nowrap">13a-16</FONT> or
<FONT STYLE="white-space:nowrap">15d-16</FONT> </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Under the Securities Exchange Act of 1934 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>For the month of March, 2025 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Commission File Number: <FONT STYLE="white-space:nowrap">001-38336</FONT> </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center> <P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:20pt; font-family:Times New Roman" ALIGN="center"><B>NUTRIEN LTD. </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>(Name of
registrant) </B></P> <P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center> <P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Suite 1700, 211 19th Street East </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Saskatoon, Saskatchewan, Canada </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>S7K 5R6 </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>(Address of
principal executive office) </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center> <P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Indicate by check mark whether the registrant files or will file annual reports under cover of Form <FONT STYLE="white-space:nowrap">20-F</FONT> or Form <FONT
STYLE="white-space:nowrap">40-&nbsp;F.</FONT> </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Form <FONT STYLE="white-space:nowrap">20-F</FONT> &#9744; Form <FONT
STYLE="white-space:nowrap">40-F</FONT> &#9746; </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&nbsp;</P>
<P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>SIGNATURE </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by
the undersigned, thereunto duly authorized. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="44%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="4%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="5%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="44%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="3"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>NUTRIEN LTD.</B></P> <P STYLE="font-size:18pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">Date: March&nbsp;11, 2025</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Noralee Bradley&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Name:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Noralee Bradley</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Title:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Executive Vice President, External Affairs and Chief Sustainability and Legal Officer</TD></TR>
</TABLE>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>EXHIBIT INDEX </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD></TD>

<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD WIDTH="91%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:10pt; font-family:Times New Roman; "><B>Exhibit</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Description of Exhibit</B></P></TD></TR>


<TR STYLE="font-size:1pt">
<TD HEIGHT="13"></TD>
<TD HEIGHT="13" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>99.1</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="d937713dex991.htm">News Release dated March&nbsp;11, 2025 </A></TD></TR>
</TABLE>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>d937713dex991.htm
<DESCRIPTION>EX-99.1
<TEXT>
<HTML><HEAD>
<TITLE>EX-99.1</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE" STYLE="line-height:Normal">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL" ALIGN="right"><B>Exhibit 99.1 </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:11pt" ALIGN="center">


<TR>

<TD WIDTH="51%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="48%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:36pt">
<TD VALIGN="top">


<IMG SRC="g937713g0312035706426.jpg" ALT="LOGO">
</TD>
<TD VALIGN="bottom" ROWSPAN="2">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ROWSPAN="2" NOWRAP> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:36pt; font-family:ARIAL" ALIGN="right"><B>News Release</B></P>
<P STYLE="font-size:12pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:36pt">
<TD VALIGN="top"><FONT STYLE="font-size:11pt">NYSE, TSX: NTR</FONT></TD></TR>
</TABLE> <P STYLE="font-size:4pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000">&nbsp;</P>
<P STYLE="margin-top:4pt; margin-bottom:0pt; font-size:11pt; font-family:ARIAL">March&nbsp;11, 2025 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:18pt; font-family:ARIAL" ALIGN="center"><B>Nutrien Prices Offering of an Aggregate of
US$1.0 Billion of <FONT STYLE="white-space:nowrap">2-Year</FONT> and <FONT STYLE="white-space:nowrap">7-Year</FONT> Senior Notes </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:11pt; font-family:ARIAL" ALIGN="justify"><B>SASKATOON,
Saskatchewan</B> &#150; Nutrien Ltd. (TSX and NYSE: NTR) today announced the pricing of US$400 million aggregate principal amount of 4.500&nbsp;percent senior notes due March&nbsp;12, 2027 and US$600&nbsp;million aggregate principal amount of
5.250&nbsp;percent senior notes due March&nbsp;12, 2032 (together, the &#147;senior notes&#148;). The offering is expected to close on or about March&nbsp;13, 2025, subject to customary closing conditions. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:11pt; font-family:ARIAL" ALIGN="justify">Nutrien intends to use the net proceeds from this offering to repay its US$500&nbsp;million aggregate principal amount of 3.000% senior notes upon their
maturity on April&nbsp;1, 2025 and its US$500&nbsp;million aggregate principal amount of 5.950% senior notes upon their maturity on November&nbsp;7, 2025, pending which such proceeds may be used to reduce outstanding indebtedness under its
short-term credit facilities, to finance working capital and for general corporate purposes. The senior notes will be unsecured and rank equally with Nutrien&#146;s existing senior unsecured debt. The joint book-running managers for the offering are
Barclays Capital Inc., BMO Capital Markets Corp., Citigroup Global Markets Inc., and TD Securities (USA) LLC. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:11pt; font-family:ARIAL" ALIGN="justify">The offering will be made by way of a
prospectus supplement dated March&nbsp;11, 2025, to Nutrien&#146;s short form base shelf prospectus dated March&nbsp;22, 2024, filed with the securities regulatory authorities in each of the provinces of Canada, which forms a part of and is included
in Nutrien&#146;s registration statement on Form <FONT STYLE="white-space:nowrap">F-10,</FONT> filed in the United States with the Securities and Exchange Commission (the &#147;SEC&#148;) under the multijurisdictional disclosure system in Canada and
the United States. The senior notes will not be offered in Canada or to any resident of Canada. A final prospectus supplement in respect of the offering of the senior notes will be filed with the same regulatory authorities in Canada and the SEC.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:ARIAL"><B>About Nutrien </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:11pt; font-family:ARIAL" ALIGN="justify">Nutrien is a leading global provider of
crop inputs and services. We operate a world-class network of production, distribution and ag retail facilities that positions us to efficiently serve the needs of growers. We focus on creating long-term value by prioritizing investments that
strengthen the advantages of our business across the ag value chain and by maintaining access to the resources and the relationships with stakeholders needed to achieve our goals. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:ARIAL"><B>Advisory </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:11pt; font-family:ARIAL" ALIGN="justify"><I>The senior notes are being offered in the
United States pursuant to an effective registration statement (including a base shelf prospectus) filed with the SEC. Nutrien has filed a preliminary prospectus supplement related to the offering of the senior notes. Before you invest, you should
read the preliminary prospectus supplement, the accompanying base shelf prospectus and other documents that are incorporated by reference therein for more complete information about Nutrien and this offering. </I></P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:11pt; font-family:ARIAL" ALIGN="justify"><I>The preliminary prospectus supplement and the accompanying base shelf prospectus are available for
free on the SEC website at www.sec.gov. Alternatively, the documents may be obtained by contacting Barclays Capital Inc., c/o Broadridge Financial Solutions, 1155 Long Island Avenue, Edgewood, New York 11717 by email at
</I><I><U>barclaysprospectus@broadridge.com</U></I><I> or by telephone at <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">1-888-603-5847;</FONT></FONT></FONT> BMO Capital Markets Corp., 151 West
42</I><I><SUP STYLE="font-size:75%; vertical-align:top">nd</SUP></I><I> Street, New York, NY 10036, Attention: Legal Department, by telephone at
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">1-866-864-7760;</FONT></FONT></FONT> Citigroup Global Markets Inc., c/o Broadridge Financial Solutions, 1155 Long Island Avenue, Edgewood, NY 11717,
by email at </I><I><U>prospectus@citi.com</U></I><I> or by telephone at <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">1-800-831-9146</FONT></FONT></FONT> and TD Securities (USA) LLC, 1 Vanderbilt
Avenue, New York, NY 10017, by telephone at <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">1-855-495-9846</FONT></FONT></FONT></I>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:11pt; font-family:ARIAL" ALIGN="justify"><I>This press release shall not constitute an offer to sell or the solicitation of an offer to buy nor shall there be any sale of the senior notes in
any jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of such jurisdiction. </I></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:ARIAL"><B>Forward-Looking Statements </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:11pt; font-family:ARIAL" ALIGN="justify"><I>Certain statements and other
information included in this press release constitute &#147;forward-looking information&#148; or &#147;forward-looking statements&#148; (collectively, &#147;forward-looking statements&#148;) under applicable securities laws (such statements are
often accompanied by words such as &#147;should&#148;, &#147;could&#148;, &#147;expect&#148;, &#147;may&#148;, &#147;anticipate&#148;, &#147;forecast&#148;, &#147;believe&#148;, &#147;intend&#148;, &#147;estimate&#148;, &#147;plan&#148; or other
similar words). All statements in this press release, other than those relating to historical information or current conditions, are forward-looking statements, including, but not limited to, forecasts and statements as to management&#146;s
expectations with respect to, among other things, the intended use of proceeds of the offering and the timing of closing of the offering. Such forward-looking statements involve known and unknown risks and uncertainties, many of which are beyond our
control, as well as various assumptions and business sensitivities, including those risk factors referred to in the preliminary prospectus supplement referenced in this press release and those referred to under the heading &#147;Risk Factors&#148;
in Nutrien&#146;s annual information form for the year ended December&nbsp;31, 2024 and under the heading &#147;Key Enterprise Risks&#148; in Nutrien&#146;s management&#146;s discussion and analysis for the year ended December&nbsp;31, 2024, which
may cause actual results, performance or achievements of Nutrien, which includes the offering being delayed or not completed, to be materially different from any future results, performance or achievements expressed or implied by such
forward-looking statements. Nutrien disclaims any intention or obligation to update or revise any forward-looking statements in this press release as a result of new information or future events, except as may be required under applicable Canadian
securities legislation or applicable U.S. federal securities law. These forward-looking statements are based on certain assumptions and analyses made by us in light of our experience and perception of historical trends, current conditions and
expected future developments as well as other factors we believe are appropriate in the circumstances. All of the forward-looking statements contained herein are qualified by these cautionary statements and by the assumptions that are stated or
inherent in such forward-looking statements. Although we believe these assumptions are reasonable, undue reliance should not be placed on these assumptions and such forward-looking statements. </I></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:ARIAL"><B>FOR FURTHER INFORMATION: </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:11pt; font-family:ARIAL">Jeff Holzman </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:11pt; font-family:ARIAL">Vice President, Investor Relations </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:11pt; font-family:ARIAL">(306)
<FONT STYLE="white-space:nowrap">933-8545</FONT> </P>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>g937713g0312035706426.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g937713g0312035706426.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1"  X -D# 2(  A$! Q$!_\0
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M]JR* 2% R>OX5R7P2^(/BCQ'XDN=,U>]:^MA 9 \B*&C(]P!P?>@#WJBBB@
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M2O%/!GCC5_ VJ->Z6T;"1=LL,P)20>^.<^XKO=1_:+\375J8K+3]/LI&&/.
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MT"PZMIMK>QJ<J)X@VT^V>E%% "Z1H>EZ!:M;:386]G S;BD*!03ZU?(#*58
M@C!!'6BB@#D]0^&/@K5)VFNO#ED9&.6:)3%D_P# "*DTSX;>#-(F6:R\.V*R
MJ<J\B&0CZ;R<444 =0    , = *S9/#FAS2-)+HVG22.=S,UJA+'U)Q110!?
M@@AM8%@MXHXHD&%CC4*JCV JO>:3IVHNKWVGVMRR#"F>%7('MD444 +9Z7I^
:G%S8V%K:E_O>1"J;OK@<U;HHH *2BB@#_]D!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
